Skip to main content
Fig. 2 | International Journal of Retina and Vitreous

Fig. 2

From: Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial

Fig. 2

Vitreous hemorrhage score progression during the 24-week study period in both groups. Note the faster reduction in Group B score (these eyes were treated with IVB and PPV) when compared to Group A (these eyes were treated with IVB only). However, after 24 weeks, the mean score are similar in both groups

Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us